What is Mytesi, and how does it work?

Mytesi (crofelemer delayed-release tablets) is an anti-diarrheal indicated for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy.

What are the side effects of Mytesi?

Common side effects of Mytesi include:

What is the dosage for Mytesi?

  • Before starting Mytesi, rule out infectious etiologies of diarrhea.
  • The recommended adult dosage of Mytesi is 125 mg taken orally two times a day, with or without food.
  • Do not crush or chew Mytesi tablets.
  • Swallow whole.

What drugs interact with Mytesi?

Nelfinavir, Zidovudine, And Lamivudine

Is Mytesi safe to use while pregnant or breastfeeding?

  • There are no adequate, well-controlled studies in pregnant women.
  • This drug should be used during pregnancy only if clearly needed.
  • It is not known whether crofelemer is excreted in human milk.
  • Because many drugs are excreted in human milk and because of the potential for adverse reactions in nursing infants from Mytesi, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Summary

Mytesi (crofelemer delayed-release tablets) is an anti-diarrheal indicated for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy. Common side effects of Mytesi include upper respiratory tract infection, bronchitis, cough, gas, increased bilirubin, nausea, back pain, joint pain, urinary tract infection (UTI), and others.

Treatment & Diagnosis

Medications & Supplements

SLIDESHOW

A Timeline of the HIV/AIDS Pandemic See Slideshow

Health Solutions From Our Sponsors

FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Medically Reviewed on 12/18/2020
References
All sections courtesy of the U.S. Food and Drug Administration